RECORDATI: SHAREHOLDERS APPROVE THE 2016 ACCOUNTS. DIVIDEND

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
137
RECORDATI: SHAREHOLDERS APPROVE THE 2016 ACCOUNTS. DIVIDEND € 0.70 PER SHARE (+16.7% vs 2015)
  • Shareholders approve the 2016 results: consolidated revenues € 1,153.9 million (+10.1% vs 2015) , operating income € 327.4 million (+17.6%) , net income € 237.4 million (+19.4%).
  • Dividend for 2016 € 0.70 per share (+16.7% vs 2015) , of which € 0.35 already paid in November 2016.
  • Appointment of the Board of Directors, composed of 9 members, 6 of which independent, for the 2017-2019 three-year period.
  • Appointment of the Board of Statutory Auditors for the 2017-2019 three-year period.
  • Remuneration policy approved.
  • Authorization to buy-back and dispose of Recordati shares renewed.
  • Renewal of the five-year authorization for the Board of Directors to increase capital and to issue convertible bonds for a maximum amount of € 50,000,000 and € 80,000,000 respectively .
  • First quarter 2017 consolidated revenues € 342 million (+13% vs the first quarter of 2016).

Milan, 11 April 2017 - Today the Annual and Extraordinary Meeting of Recordati S.p.A. Shareholders was held.

Recordati S.p.A.'s Annual Shareholders' Meeting approved the company's 2016 financial accounts, which were prepared according to IAS/IFRS.  In addition, the group's consolidated statements, which were also prepared according to IAS/IFRS, were presented.  The tables attached contain a summary of the 2016 financial statements which were commented in the press release issued on 1 March 2017. In 2016 consolidated revenues were € 1,153.9 million (+10.1%), operating income (EBIT) was € 327.4 million (+17.6%), and net income was € 237.4 million (+19.4%).  International sales account for 79.4% of total sales.

As proposed by the Board of Directors, the shareholders approved a dividend of € 0.35 per share, in full balance of the interim 2016 dividend of € 0.35, to be paid to all shares outstanding at ex-dividend date, excluding those in treasury stock, as from 26 April 2017 (record date 25 April 2017), with ex-dividend on 24 April 2017 (against presentation of coupon no. 19). The full 2016 dividend is therefore of € 0.70 per share (€ 0.60 per share in 2015).

Further shareholder resolutions

Appointment of the members of the Board of Directors and Board of Statutory Auditors

The shareholders appointed the Board of Directors for the years 2017-2019 (until the Annual Shareholders' Meeting which will approve the 2019 financial statements) which is composed of nine members, by approving the proposal made by the majority shareholder FIMEI S.p.A. to confirm Alberto Recordati, Andrea Recordati, Fritz Squindo, Rosalba Casiraghi, Michaela Castelli, Marco Vitale, Mario Garraffo and Paolo Fresia and to appoint Elisa Corghi as a new member. The shareholders, furthermore, appointed the Statutory Auditors for the years 2017-2019 (until the Annual Shareholders' Meeting which will approve the 2019 financial statements) by electing Marco Nava (Auditor), Livia Amidani Aliberti (Auditor) and Patrizia Paleologo Oriundi (Alternate Auditor) from the list presented by the majority shareholder FIMEI S.p.A., and Antonio Santi (President) and Andrea Balelli (Alternate Auditor) from the list presented by other institutional shareholders who hold 0.7591% of the share capital.

The professional résumés of the members of the new Board of Directors and the new Statutory Auditors are available on the company's website under the Shareholders Meetings title in the Investors section.

The shareholders also approved the remuneration for the Board of Directors and the Statutory Auditors.

Remuneration policy

The Shareholders' Meeting also approved the remuneration policies for the year 2017 in accordance with article 123 ter of Legislative Decree No. 58 of 24February 1998 which is the object of the Board's explanatory report on the fourth item of the agenda of the Shareholders' Meeting and can be found on the company's website under the Shareholders Meetings title in the Investors section.

Authorization to buy-back and dispose of Recordati shares

The Shareholders' Meeting authorized the buyback and disposal of Recordati shares until the Annual Shareholders' Meeting that will approve the 2017 financial statements. The objective of the proposal to renew the authorization to buy back and dispose of Recordati shares until the Annual Shareholders' Meeting which will approve the 2017 financial statements is, as in previous years, to grant the Board the possibility: of using shares for equity acquisitions or as consideration for strategic agreements; of allowing the company to invest in its own shares; and of constituting a stock of own shares to service current and future stock option plans. The company would be allowed to purchase up to 10,000,000 Recordati existing ordinary (common) shares, which includes those shares held in Treasury stock at any given time, for a maximum cash outlay of € 300,000,000.  The purchase price must be at least equal to the shares' nominal value (€ 0.125) and must not exceed the average official Stock Exchange price recorded over the 5 trading days prior to the transaction, plus 5%.  Possible purchases will be made on regulated markets and must comply with article 132 of Legislative Decree 58/1998 and with article 144-bis, paragraph 1.b) of the Issuers' Regulations as approved by CONSOB's resolution 11971/1999 and with market practice allowed and recognized by CONSOB.  At 10 April 2017 the company has 3,091,261 shares in Treasury stock which amounts to 1.478% of the current share capital.

*** Extraordinary Meeting

Today's Extraordinary Meeting resolved to renew the authorization, which is about to expire, for the Board of Directors to increase the company's share capital on one or more occasions, gratuitously or against payment, by issuing ordinary shares and/or share subscription warrants, for a maximum nominal amount of € 50,000,000, and to issue, on one or more occasions, for a maximum nominal amount of € 80,000,000, bonds convertible into ordinary shares, or with share subscription warrants, for a period not exceeding five years from the date of the resolution, with the consequent modification of article 6 of the company's by-laws. The previous authorization granted by the Shareholders Meeting of 19 April 2012, which will expire on 19 April 2017, is therefore revoked.

Meeting of the Board of Directors following the Shareholders' Meeting

The new Board of Directors, in a meeting held following the Shareholders' Meeting, confirmed Alberto Recordati as Chairman and Andrea Recordati as Vice Chairman and CEO, and confirmed the same powers granted previously to the latter.

The Board therefore confirmed, taking into account their functions, Alberto Recordati, Chairman, Andrea Recordati Vice Chairman and CEO, and Fritz Squindo, Managing Director e CFO, as executive directors.

The Board, using as a basis the Directors' statements and available information, verified the effective existence of the independence requisites, pursuant both to Legislative Decree 58/1998 and to the Corporate Governance Code adopted by the company (see the Corporate Governance and Ownership Structure Report for 2016), concerning the Directors who declared to possess such requisites (Rosalba Casiraghi, Michaela Castelli, Elisa Corghi, Paolo Fresia, Mario Garraffo, and Marco Vitale; all qualifying as independent). The Board therefore comprises 6 independent members out of the total of 9 members.

On the basis of the Auditors' statements and available information, the Board also verified the effective existence of the independence requisites, pursuant to Legislative Decree 58/1998 and to the Corporate Governance Code adopted by the company, of the Statutory Auditors and confirmed that all the Statutory Auditors, including Mr. Nava who has held this position for more than nine years, are independent, by sharing the result of the verification of the effective existence of the independence requisites undertaken by the Statutory Auditors following their appointment.

The Board proceeded to nominate the Audit, Risk and Sustainability Committee, integrating the functions previously assigned to the Audit and Risk Committee, additionally attributing to said Committee the supervision of the sustainability issues related to business activities and the dynamics of their interaction with all stakeholders. The Audit, Risk and Sustainability Committee is composed of the independent and non executive members Marco Vitale, President, Michaela Castelli and Elisa Corghi.

Finally, the Board of Directors resolved to nominate the Remuneration Committee, composed of the independent and non executive members: Mario Garraffo, President, Rosalba Casiraghi and Michaela Castelli. The activities which the Corporate Governance Code assigns to the Nomination Committee will be carried out by the entire Board of Directors.

First quarter 2017

Revenue performance in the first quarter 2017 is positive. Group sales are € 342 million, an increase of 13% over those in the first quarter of the preceding year and include those generated by the Italian company Italchimici S.p.A. and the Swiss company Pro Farma AG, acquired in 2016 and consolidated respectively as from 1 June and 1 July of that year. Excluding the new acquisitions sales growth would have been of 8%.

Recordati , established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,100, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa, in the United States of America, in Mexico and in some South American countries.  An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases.  Consolidated revenue for 2016 was € 1,153.9 million, operating income was € 327.4 million and net income was € 237.4 million.

For further information:

Recordati website:  www.recordati.com

Investor Relations                                                                       Media Relations                     Marianne Tatschke                                                                     Studio Noris Morano                                                            (39)0248787393                                                                          (39)0276004736, (39)0276004745 e-mail: inver@recordati.it                                                          e-mail: norismorano@studionorismorano.com                                                                     

S tatements contained in this release, other than historical facts, are "forward-looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995). These statements are based on currently available information, on current best estimates, and on assumptions believed to be reasonable. This information, these estimates and assumptions may prove to be incomplete or erroneous, and involve numerous risks and uncertainties, beyond the Company's control. Hence, actual results may differ materially from those expressed or implied by such forward-looking statements. All mentions and descriptions of Recordati products are intended solely as information on the general nature of the company's activities and are not intended to indicate the advisability of administering any product in any particular instance.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...af819443e9

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 495

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 0

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 269

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 287

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 399

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 0

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading

Top 5 Most Recently Viewed Articles

European Frozen Food Market Set for Major Growth, Companies Thrive

Updated Category News Views 277

European Frozen Food Market Set for Major Growth The frozen food market across Europe is poised for remarkable growth in the coming years, with an estimated increase of USD 62.5 billion from 2025 to 2029. With a projected compound annual growth rate (CAGR) of 7.6%, this sector is becoming increasingly attractive to investors and consumers alike. The desire for convenient...

Continue Reading
Mag Mile Capital's $10.25 Million Equity Venture in Chicago

Updated Category News Views 261

Mag Mile Capital Secures Significant Equity for Urban Transformation Mag Mile Capital, Inc. (OTCQB: MMCP) has achieved a significant milestone by securing $10.25 million in joint venture equity aimed at an innovative office-to-multifamily conversion project in Chicago. This project, situated at 111 W. Illinois, aims to repurpose a prominent office space in the vibrant...

Continue Reading
Nourishing Dogs and Communities: The Launch of Purposeful Pup Treats

Updated Category News Views 243

Purposeful Pup Treats Unveils New Launch for Furry Friends Purposeful Pup Treats, a brand passionate about the welfare of pets, has proudly launched a new range of all-natural, single-ingredient dog snacks. These treats are created with high-quality European ingredients and designed not just for the health of dogs, but also to uplift and strengthen communities. Embracing...

Continue Reading
Collaboration of Linux Foundation and ATIS to Transform Telecom

Updated Category News Views 151

Strategic Partnership for Innovative Network Solutions The Linux Foundation and the Alliance for Telecommunications Industry Solutions (ATIS) have joined forces to create a transformative impact on next-generation network architectures. This collaboration paves the way for advancements in open source and open RAN technologies, which are becoming increasingly important in...

Continue Reading
Vallourec Expands Operations with Significant Contracts

Updated Category News Views 245

Vallourec's Strategic Contracts in Iraq Vallourec, a global leader in premium seamless tubular solutions, has recently cemented two significant contracts for the supply of Oil Country Tubular Goods (OCTG). These contracts, established with major players CNOOC and PetroChina, reflect Vallourec's strength and expertise in supporting drilling operations in challenging...

Continue Reading